Page 96 - NobleCon20-Book-Project

Health Care
Date November 19, 2024 Health Care
52wk High $11.70
52wk Low $1.00 Intelligent Bio Solutions Inc INBS $1.41
135 West, 41ST Street
New York, NY 10036

(USD - in millions) ibs.inc
Market Cap 6.3
Enterprise 3.0
Basic Shares Out. 4.25 COMPANY OVERVIEW
Float 4.14
Institutional Holdings 7.97% Detailed Analysis:Channelchek.com
Short Interest 0.42 Intelligent Bio Solutions Inc. is a medical technology company
Avg. 90-Day Volume 1.78 delivering innovative, rapid, non-invasive testing solutions. The
Company believes that its Intelligent Fingerprinting Drug Screening
System will revolutionize portable testing through fingerprint sweat
analysis, which has the potential for broader applications in additional
EPS Data fields. Designed as a hygienic and cost-effective system, the test
screens for the recent use of drugs commonly found in the workplace,
2022 2023 2024 including opiates, cocaine, methamphetamine, and cannabis. With
CQ1 (21.60) (68.64) (1.43) sample collection in seconds and results in under ten minutes, this
CQ2 (33.60) (22.92) (0.51) technology would be a valuable tool for employers in safety-critical
industries.
CQ3 (19.20) (12.48) N/A
CQ4 (5.52) (2.07) N/A
CY (79.92) (106.11) N/A Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 1.39
ROE (ttm) -290.94
Debt-to-Total Cap. (mrq) 11.97
Fiscal Year End 30-Jun
N
135 West, 41S ew York NY 10036

Key Executives
CEO: Simeonidis, Harry
CFO: Sakiris, Spiro
COO: N/A
IR: Arzeno, Alex
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
rleboyer@noblelsp.com available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures